Abstract
OBJECTIVE
This study aimed to evaluate the outcomes among individuals who were eligible and
approached for participation in a randomized controlled trial during pregnancy, comparing
those who enrolled with those who declined participation.
DATA SOURCES
MEDLINE, Scopus, CINAHL, the Cochrane Library, and Ovid were searched from study inception
to May 2022.
STUDY ELIGIBILITY CRITERIA
This study included all obstetrical randomized controlled trials that reported clinical
outcomes for both participants and nonparticipants.
METHODS
The primary outcome captured the presence of morbidity. It was a composite of the
primary outcome of each study comparing the participant arm with the nonparticipant
arm. If a primary outcome was not clearly defined, a surrogate was developed on the
basis of the core outcomes for the clinical condition studied. The risk of bias was
assessed with the Newcastle-Ottawa Scale. Subgroup analyses for relevant obstetrical
and neonatal outcomes were performed. The summary comparisons were reported as odds
ratios with 95% confidence intervals computed using random-effects meta-analysis with
heterogeneity evaluated using the I2 statistic. A funnel plot was used to examine publication bias, and there was no asymmetry.
RESULTS
After reviewing more than 1100 abstracts, 17 obstetrical randomized controlled trials
(103,610, with 26,293 participants and 77,317 nonparticipants) met our inclusion criteria
and were analyzed. Of note, 9 studies were not rated as high quality, primarily for
failing to control for confounding factors. Trial interventions were categorized as
antepartum (n=11), intrapartum (n=5), or postpartum (n=1). Overall, participants in
obstetrical randomized controlled trials had no difference in outcomes compared with
nonparticipants (n=17: odds ratio, 0.88; 95% confidence interval, 0.52–1.49; I2=90%). Moreover, there was no difference seen when only randomized controlled trials
that reported a primary outcome were included (n=12: odds ratio, 0.76; 95% confidence
interval, 0.38–0.1.49; I2=93%). In addition, there was no difference noted in the subgroup where the randomized
controlled trial intervention was not available to nonparticipants (n=7: odds ratio,
0.91; 95% confidence interval, 0.45–1.85; I2=68%).
CONCLUSION
Pregnant individuals who agreed to participate in randomized controlled trials had
no difference in outcomes compared with those who decline participation. Pregnant
individuals should be provided with this reassuring information when offered to participate
in a randomized controlled trial. Moreover, this information may improve patient recruitment
into randomized controlled trials.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & Gynecology MFMAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The Tuskegee study of untreated syphilis: a case study in peripheral trauma with implications for health professionals.J Gen Intern Med. 2020; 35: 322-325
- Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.Cochrane Database Syst Rev. 2008; 2008MR000009
- Participation in clinical trials improves outcomes in women's health: a systematic review and meta-analysis.BJOG. 2017; 124: 863-871
- Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.JAMA. 2000; 283: 2008-2012
Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta analyses; 2014.
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments.BMC Med Res Methodol. 2014; 14: 45https://doi.org/10.1186/1471-2288-14-45
- Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis.Neuroepidemiology. 2016; 47: 181-191
- Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: a systematic review and meta-analysis.Int J Cardiol Heart Vasc. 2021; 33100765
- RoB 2: A revised tool for assessing risk of bias in randomised trials.BMJ. 2019; 366: l4898
- Comparison of chorion villus sampling and early amniocentesis for karyotyping in 1,492 singleton pregnancies.Fetal Diagn Ther. 1996; 11: 9-15
- Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.Am J Obstet Gynecol. 1992; 166: 1318-1323
- The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.Am J Obstet Gynecol. 1983; 146: 187-190
- The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies.Obstet Gynecol. 1981; 57: 557-565
- Pregnancy outcome among non-participants in a trial on ultrasound screening.Ultrasound Obstet Gynecol. 1998; 11: 104-109
- A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group.Arch Dis Child. 1992; 67: 1442-1446
- Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: a controlled trial with infant follow-up.Prenat Diagn. 1998; 18: 465-475
- Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.BMJ. 2012; 344: e3799
- Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm.BMJ Open. 2017; 7e017566
- Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent.Am J Obstet Gynecol MFM. 2020; 100239
- Birth After Caesarean Study Group. Planned vaginal birth or elective repeat caesarean: patient preference restricted cohort with nested randomised trial.PLoS Med. 2012; 9e1001192
- Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial.Lancet. 2009; 374: 979-988
- Do clinical trials improve quality of care? A comparison of clinical processes and outcomes in patients in a clinical trial and similar patients outside a trial where both groups are managed according to a strict protocol.Qual Saf Health Care. 2005; 14: 175-178
- Prophylactic intrapartum amnioinfusion for patients with oligohydramnios. A prospective randomized study.J Reprod Med. 1992; 37: 817-820
- Moderate neonatal morbidity after vaginal term breech delivery.J Matern Fetal Neonatal Med. 2004; 16: 357-361
- Intrapartum fetal heart rate monitoring in a combined low- and high-risk population: a controlled clinical trial.Eur J Obstet Gynecol Reprod Biol. 1986; 23: 1-11
- Effectiveness of policy to provide breastfeeding groups (BIG) for pregnant and breastfeeding mothers in primary care: cluster randomised controlled trial.BMJ. 2009; 338: a3026
- Participation in obstetric studies is associated with improved pregnancy outcomes.Am J Obstet Gynecol. 2022; 226: S773-S774https://doi.org/10.1016/j.ajog.2021.11.1269
- Recruitment difficulties in obstetric trials: a case study and review.Aust N Z J Obstet Gynaecol. 2014; 54: 546-552
- Women's and clinician's acceptability of participation in a hypothetical obstetric randomized controlled trial: a qualitative survey.J Matern Fetal Neonatal Med. 2021; ([Epub ahead of print])
Article Info
Publication History
Published online: July 15, 2022
Accepted:
July 7,
2022
Received:
July 2,
2022
Footnotes
The authors report no conflict of interest.
This study received no financial support.
This study was registered with the International Prospective Register of Systematic Reviews (registration number: CRD42021233077) on March 6, 2021.
This study was presented at the 2022 Society for Maternal-Fetal Medicine Annual Pregnancy Meeting, held virtually, January 31, 2022, to February 5, 2022.
K.S.K. is a distinguished investigator supported by the Beatriz Galindo (senior modality) Program grant given to the University of Granada by the Ministry of Science, Innovation and Universities of the Spanish Government.
All authors have completed the International Committee of Medical Journal Editors uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare no support from any organization for the submitted work, no financial relationship with any organizations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could seem to have influenced the submitted work.
The lead author (the manuscript's guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspect of the study has been omitted, and that any discrepancies from the study as planned have been explained.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
